Amalgamated Bank’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $800K | Sell |
46,236
-2,033
| -4% | -$27.9K | 0.01% | 1202 |
|
|
2026
Q1 | $600K | Buy |
48,269
+43,541
| +921% | +$585K | ﹤0.01% | 1260 |
|
|
2025
Q4 | $60K | Sell |
4,728
-783
| -14% | -$8.96K | ﹤0.01% | 1786 |
|
|
2025
Q3 | $55K | Hold |
5,511
| – | – | ﹤0.01% | 1814 |
|
|
2025
Q2 | $45K | Hold |
5,511
| – | – | ﹤0.01% | 1848 |
|
|
2025
Q1 | $46K | Buy |
5,511
+1,367
| +33% | +$11.4K | ﹤0.01% | 1806 |
|
|
2024
Q4 | $33K | Hold |
4,144
| – | – | ﹤0.01% | 1947 |
|
|
2024
Q3 | $34K | Hold |
4,144
| – | – | ﹤0.01% | 1958 |
|
|
2024
Q2 | $26K | Hold |
4,144
| – | – | ﹤0.01% | 2024 |
|
|
2024
Q1 | $25K | Sell |
4,144
-5,812
| -58% | -$32.8K | ﹤0.01% | 2044 |
|
|
2023
Q4 | $60K | Sell |
9,956
-1,021
| -9% | -$4.55K | ﹤0.01% | 2164 |
|
|
2023
Q3 | $46K | Hold |
10,977
| – | – | ﹤0.01% | 2287 |
|
|
2023
Q2 | $34K | Sell |
10,977
-3,208
| -23% | -$6.83K | ﹤0.01% | 2475 |
|
|
2023
Q1 | $20K | Sell |
14,185
-2,161
| -13% | -$4.3K | ﹤0.01% | 2639 |
|
|
2022
Q4 | $33K | Hold |
16,346
| – | – | ﹤0.01% | 2598 |
|
|
2022
Q3 | $33K | Buy |
16,346
+266
| +2% | +$745 | ﹤0.01% | 2625 |
|
|
2022
Q2 | $51K | Sell |
16,080
-155
| -1% | -$562 | ﹤0.01% | 2466 |
|
|
2022
Q1 | $68K | Sell |
16,235
-1,370
| -8% | -$6.07K | ﹤0.01% | 2326 |
|
|
2021
Q4 | $84K | Sell |
17,605
-190
| -1% | -$947 | ﹤0.01% | 2079 |
|
|
2021
Q3 | $95K | Sell |
17,795
-1,036
| -6% | -$5.21K | ﹤0.01% | 2084 |
|
|
2021
Q2 | $96K | Buy |
18,831
+4,821
| +34% | +$27.4K | ﹤0.01% | 2123 |
|
|
2021
Q1 | $94K | Sell |
14,010
-1,403
| -9% | -$7.78K | ﹤0.01% | 1556 |
|
|
2020
Q4 | $70K | Buy |
15,413
+88
| +0.6% | +$390 | ﹤0.01% | 1544 |
|
|
2020
Q3 | $59K | Sell |
15,325
-359
| -2% | -$1.53K | ﹤0.01% | 1447 |
|
|
2020
Q2 | $75K | Sell |
15,684
-3,852
| -20% | -$15.9K | ﹤0.01% | 1428 |
|
|
2020
Q1 | $68K | Sell |
19,536
-598
| -3% | -$2.53K | ﹤0.01% | 1537 |
|
|
2019
Q4 | $97K | Buy |
20,134
+3,324
| +20% | +$11.6K | ﹤0.01% | 1737 |
|
|
2019
Q3 | $49K | Sell |
16,810
-135
| -0.8% | -$471 | ﹤0.01% | 1711 |
|
|
2019
Q2 | $121K | Buy |
16,945
+3,760
| +29% | +$38.4K | ﹤0.01% | 1668 |
|
|
2019
Q1 | $187K | Buy |
13,185
+342
| +3% | +$4.52K | ﹤0.01% | 1521 |
|
|
2018
Q4 | $174K | Buy |
+12,843
| New | +$231K | ﹤0.01% | 1438 |
|
|
2018
Q3 | – | Sell |
-13,293
| Closed | -$218K | – | 1450 |
|
|
2018
Q2 | $218K | Buy |
+13,293
| New | +$233K | 0.01% | 1520 |
|
Other funds holding AMRX
WW
PCM
PFC
CAM
Amalgamated Bank's AMRX Position: Q2 2026 in Review
Amalgamated Bank reduced its Amneal Pharmaceuticals (AMRX) stake by 4.2% in Q2 2026, selling an estimated $27.9K and leaving 46,236 shares worth $800K. The position accounts for 0.01% of the portfolio, ranked #1202.
Amalgamated Bank first reported a position in AMRX in Q2 2018 and has held it in 32 quarters since. 136 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Amalgamated Bank held 46,236 shares of Amneal Pharmaceuticals worth $800K as of Q2 2026.
- Amalgamated Bank sold 2,033 Amneal Pharmaceuticals shares in Q2 2026, an estimated $27.9K.
- Amneal Pharmaceuticals made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1202 holding.
- Amalgamated Bank first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 32 quarters since.
- 136 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.